Neogen Corporation (NEOG) analyst actions
NEOG analyst actions moved a median of +0.46% by the close. Rating and price-target actions on NEOG in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the NEOG overview →
14 measured NEOG analyst action events.
Where these NEOG analyst actions landedvs 13 measured NEOG analyst action reactions
| Middle 50% of NEOG analyst action reactions | -0.89% to +2.46% |
|---|---|
| Median reaction (to close) | +0.46% |
| Measured reactions | 13 |
Point-in-time · zero look-ahead
Half of the 13 NEOG analyst action events with a measured close landed between -0.89% and +2.46%; 54% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Neogen Corporation (NEOG) And Encourages Shareholders to Reach Out | Press release | — | — | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Neogen Corporation (NEOG) And Encourages Stockholders to Reach Out | Press release | +0.17% | -1.01% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Neogen Corporation (NEOG) And Encourages Shareholders to Reach Out | Press release | +0.11% | +2.62% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Neogen Corporation (NEOG) And Encourages Stockholders to Reach Out | Press release | +0.05% | -0.70% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Neogen Corporation (NEOG) And Encourages Shareholders to Reach Out | Press release | +0.55% | +0.46% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Neogen Corporation (NEOG) And Encourages Shareholders to Reach Out | Press release | -0.31% | +2.46% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Neogen Corporation (NEOG) And Encourages Stockholders to Reach Out | Press release | +1.16% | +3.71% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Neogen Corporation (NEOG) And Encourages Stockholders to Reach Out | Press release | +0.00% | +2.63% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Neogen Corporation (NEOG) And Encourages Shareholders to Reach Out | Press release | +0.32% | +1.74% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Neogen Corporation (NEOG) And Encourages Stockholders to Reach Out | Press release | +0.40% | -0.89% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Neogen Corporation (NEOG) And Encourages Shareholders to Reach Out | Press release | +0.34% | -1.17% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Neogen Corporation (NEOG) And Encourages Stockholders to Reach Out | Press release | +0.70% | -0.09% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Neogen Corporation (NEOG) And Encourages Shareholders to Reach Out | Press release | +0.76% | -4.87% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Neogen Corporation (NEOG) And Encourages Stockholders to Reach Out | Press release | +0.00% | +0.53% |
Keep exploring
More NEOG: earnings → · SEC filings → · NEOG overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | 1,147 | -0.01% | 50% |
| Epizyme, Inc. (EPZM) | 1,145 | +0.04% | 51% |
| Pacira BioSciences, Inc. (PCRX) | 1,143 | -0.04% | 48% |
| Anthem, Inc. (ANTM) | 1,140 | -0.01% | 49% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.